Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 514753, 7 pages
http://dx.doi.org/10.1155/2014/514753
Review Article

Brachyury: A Diagnostic Marker for the Differential Diagnosis of Chordoma and Hemangioblastoma versus Neoplastic Histological Mimickers

1Department of Human Pathology “G. Barresi”, University of Messina, Italy
2Dipartimento di Patologia Umana, Azienda Ospedaliera Universitaria “Policlinico G. Martino”, Pad. D, Via Consolare Valeria 1, 98125 Messina, Italy

Received 17 June 2013; Accepted 6 November 2013; Published 21 January 2014

Academic Editor: Upender Manne

Copyright © 2014 Valeria Barresi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Showell, O. Binder, and F. L. Conlon, “T-box genes in early embryogenesis,” Developmental Dynamics, vol. 229, no. 1, pp. 201–218, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. B. G. Herrmann, “Expression pattern of the Brachyury gene in whole-mount T(Wis)/T(Wis) mutant embryos,” Development, vol. 113, no. 3, pp. 913–917, 1991. View at Google Scholar · View at Scopus
  3. A. Kispert and B. G. Herrmann, “Immunohistochemical analysis of the Brachyury protein in wild-type and mutant mouse embryos,” Developmental Biology, vol. 161, no. 1, pp. 179–193, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Vujovic, S. Henderson, N. Presneau et al., “Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas,” Journal of Pathology, vol. 209, no. 2, pp. 157–165, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. R. Salisbury, “The pathology of the notochord: review article,” The Journal of Pathology, vol. 171, pp. 153–155, 1993. View at Google Scholar
  6. V. Barresi, M. Caffo, C. Alafaci, F. Granata, and G. Tuccari, “Intradural chordoma of the Meckel's cave: a challenging differential diagnosis,” Neuropathology, vol. 32, pp. 577–582, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Barresi, M. Caffo, G. Branca, R. Caltabiano, and G. Tuccari, “Meningeal tumors histologically mimicking meningioma,” Pathology, Research & Practice, vol. 208, pp. 567–577, 2012. View at Google Scholar
  8. N. A. Jambhekar, B. Rekhi, K. Thorat, R. Dikshit, M. Agrawal, and A. Puri, “Revisiting chordoma with brachyury, a “new age” marker: analysis of a validation study on 51 cases,” Archives of Pathology and Laboratory Medicine, vol. 134, no. 8, pp. 1181–1187, 2010. View at Google Scholar · View at Scopus
  9. G. J. Oakley, K. Fuhrer, and R. R. Seethala, “Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis,” Modern Pathology, vol. 21, no. 12, pp. 1461–1469, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. R. Sangoi, M. S. Dulai, A. H. Beck, D. J. Brat, and H. Vogel, “Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation,” American Journal of Surgical Pathology, vol. 33, no. 5, pp. 669–681, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. R. Sangoi, J. Karamchandani, B. Lane et al., “Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases,” Modern Pathology, vol. 24, no. 3, pp. 425–429, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Tirabosco, D. C. Mangham, A. E. Rosenberg et al., “Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue,” American Journal of Surgical Pathology, vol. 32, no. 4, pp. 572–580, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. D. M. Park, Z. Zhuang, L. Chen et al., “Von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells,” PLoS Medicine, vol. 4, no. 2, article e60, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Yoshida, R. Oda, J. Shibahara, M. Fukayama, and H. Tsuda, “Soft-tissue hemangioblastoma of the retroperitoneum: a case study and review of the literature,” Applied Immunohistochemistry and Molecular Morphology, vol. 18, no. 5, pp. 479–482, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. T. L. Huber, V. Kouskoff, H. J. Fehling, J. Palis, and G. Keller, “Haemangioblast commitment is initiated in the primitive streak of the mouse embryo,” Nature, vol. 432, no. 7017, pp. 625–630, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. M. L. McMaster, A. M. Goldstein, C. M. Bromley, N. Ishibe, and D. M. Parry, “Chordoma: incidence and survival patterns in the United States, 1973–1995,” Cancer Causes and Control, vol. 12, no. 1, pp. 1–11, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Z. Amer and M. Hameed, “Intraosseous benign notochordal cell tumor,” Archives of Pathology and Laboratory Medicine, vol. 134, no. 2, pp. 283–288, 2010. View at Google Scholar · View at Scopus
  18. D. I. Bhat, M. Yasha, A. Rojin, S. Sampath, and S. K. Shankar, “Intradural clival chordoma: a rare pathological entity,” Journal of Neuro-Oncology, vol. 96, no. 2, pp. 287–290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Steenberghs, C. Kiekens, J. Menten, and J. Monstrey, “Intradural chordoma without bone involvement: case report and review of the literature,” Journal of Neurosurgery, vol. 97, no. 1, pp. 94–97, 2002. View at Google Scholar · View at Scopus
  20. K. Nishigaya, M. Kaneko, Y. Ohashi, and H. Nukui, “Intradural retroclival chordoma without bone involvement: no tumor regrowth 5 years after operation. Case report,” Journal of Neurosurgery, vol. 88, no. 4, pp. 764–768, 1998. View at Google Scholar · View at Scopus
  21. C. Fisher and M. Miettinen, “Parachordoma: a clinicopathologic and immunohistochemical study of four cases of an unusual soft tissue neoplasm,” Annals of Diagnostic Pathology, vol. 1, no. 1, pp. 3–10, 1997. View at Google Scholar · View at Scopus
  22. J. M. Mirra, C. Della Rocca, S. D. Nelson, and F. Martens, “Chordoma,” in Pathology and Genetics of Tumours of Soft Tissue and Bone, C. D. M. Fletcher, K. Unni, and F. Mertens, Eds., pp. 316–317, IARCC Press, Lyon, France, 2002. View at Google Scholar
  23. B. J. O'Hara, A. Paetau, and M. Miettinen, “Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma,” Human Pathology, vol. 29, no. 2, pp. 119–126, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. J. M. Meis and A. A. Giraldo, “Chordoma: an immunohistochemical study of 20 cases,” Archives of Pathology and Laboratory Medicine, vol. 112, no. 5, pp. 553–556, 1988. View at Google Scholar · View at Scopus
  25. A. Perry, D. N. Louis, B. W. Scheithauer, H. Budka, and A. von Deimling, “Meningiomas,” in WHO Classification of Tumors of the Central Nervous System, D. N. Louis, H. Ohgaki, O. D. Wiestler, and W. K. Cavenee, Eds., pp. 164–172, IARCC Press, Lyon, France, 2007. View at Google Scholar
  26. V. Barresi, E. Vitarelli, G. Branca, M. Antonelli, F. Giangaspero, and G. Barresi, “Expression of brachyury in hemangioblastoma: potential use in differential diagnosis,” The American Journal of Surgical Pathology, vol. 36, pp. 1052–1057, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. E. Couce, F. V. Aker, and B. W. Scheithauer, “Chordoid meningioma: a clinicopathologic study of 42 cases,” American Journal of Surgical Pathology, vol. 24, no. 7, pp. 899–905, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Hayashi, R. Haba, Y. Kushida et al., “Cytopathologic features of orbital intraosseous chordoid meningioma: report of a case and distinction from other myxoid/mucoid tumors,” Diagnostic Cytopathology, vol. 38, no. 11, pp. 818–821, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Tokgoz, Y. A. Oner, M. Kaymaz, M. Ucar, G. Yilmaz, and T. E. Tali, “Primary intraosseous meningioma: CT and MRI appearance,” American Journal of Neuroradiology, vol. 26, no. 8, pp. 2053–2056, 2005. View at Google Scholar · View at Scopus
  30. J. E. Lantos, N. P. Agaram, J. H. Healey, and S. Hwang, “Recurrent skeletal extra-axial chordoma confirmed with brachyury: imaging features and review of the literature,” Skeletal Radiology, vol. 42, pp. 1451–1459, 2013. View at Google Scholar
  31. S. R. Lauer, M. A. Edgar, J. M. Gardner, A. Sebastian, and S. W. Weiss, “Soft tissue chordomas: a clinicopathologic analysis of 11 cases,” The American Journal of Surgical Pathology, vol. 37, pp. 719–726, 2013. View at Google Scholar
  32. R. R. Lonser, G. M. Glenn, M. Walther et al., “Von Hippel-Lindau disease,” The Lancet, vol. 361, no. 9374, pp. 2059–2067, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. J. E. Conway, D. Chou, R. E. Clatterbuck, H. Brem, D. M. Long, and D. Rigamonti, “Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease,” Neurosurgery, vol. 48, no. 1, pp. 55–63, 2001. View at Google Scholar · View at Scopus
  34. H. Takeuchi, N. Hashimoto, R. Kitai, and T. Kubota, “A report of supratentorial leptomeningeal hemangioblastoma and a literature review,” Neuropathology, vol. 28, no. 1, pp. 98–102, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. Y.-T. Ip, J.-Q. Yuan, H. Cheung, and J. K. C. Chan, “Sporadic hemangioblastoma of the kidney: an underrecognized pseudomalignant tumor?” American Journal of Surgical Pathology, vol. 34, no. 11, pp. 1695–1700, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Liu, X. S. Qiu, and E. H. Wang, “Sporadic hemangioblastoma of the kidney: a rare renal tumor,” Diagnostic Pathology, vol. 7, article 49, 2012. View at Google Scholar
  37. W.-H. Yin, J. Li, and J. K. C. Chan, “Sporadic haemangioblastoma of the kidney with rhabdoid features and focal CD10 expression: report of a case and literature review,” Diagnostic Pathology, vol. 7, article 39, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Deb, S. Pal, V. Dutta, A. Srivastava, A. Bhargava, and K. K. Yadav, “Adrenal haemangioblastoma presenting as phaeochromocytoma: a rare manifestation of extraneural hemangioblastoma,” Endocrine Pathology, vol. 23, pp. 187–190, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. K. T. Patton, R. L. Satcher Jr., and W. B. Laskin, “Capillary hemangioblastoma of soft tissue: report of a case and review of the literature,” Human Pathology, vol. 36, no. 10, pp. 1135–1139, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. K. D. Aldape, K. H. Plate, A. O. Vortmeyer, and O. D. Zagzag, “Hemangioblastoma,” in WHO Classification of Tumors of the Central Nervous System, D. N. Louis, H. Ohgaki, O. D. Wiestler, and W. K. Cavenee, Eds., pp. 184–186, IARCC Press, Lyon, France, 2007. View at Google Scholar
  41. A. Abou-Hamden, B. Koszyca, P. G. Carney, N. Sandhu, and P. C. Blumbergs, “Metastasis of renal cell carcinoma to haemangioblastoma of the spinal cord in von Hippel-Lindau disease: case report and review of the literature,” Pathology, vol. 35, no. 3, pp. 224–227, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Mottolese, H. Stan, F. Giordano, D. Frappaz, D. Alexei, and N. Streichenberger, “Case reports metastasis of clear-cell renal carcinoma to cerebellar hemangioblastoma in von hippel lindau disease: rare or not investigated?” Acta Neurochirurgica, vol. 143, no. 10, pp. 1059–1063, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. E. M. Carney, P. Banerjee, C. L. Ellis et al., “PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: a helpful combination in the differential diagnosis with metastatic clear cell renal cellcarcinoma to the central nervous system,” American Journal of Surgical Pathology, vol. 35, no. 2, pp. 262–267, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. M. P. Hoang and R. H. Amirkhan, “Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma,” American Journal of Surgical Pathology, vol. 27, no. 8, pp. 1152–1156, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. B. Ingold, P. J. Wild, A. Nocito et al., “Renal cell carcinoma marker reliably discriminates central nervous system haemangioblastoma from brain metastases of renal cell carcinoma,” Histopathology, vol. 52, no. 6, pp. 674–681, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. S.-M. Jung and T.-T. Kuo, “Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma,” Modern Pathology, vol. 18, no. 6, pp. 788–794, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. A. L. Rivera, H. Takei, J. Zhai, S. S. Shen, J. Y. Ro, and S. Z. Powell, “Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma,” Neuropathology, vol. 30, no. 6, pp. 580–585, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. N. Weinbreck, B. Marie, A. Bressenot et al., “Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining,” American Journal of Surgical Pathology, vol. 32, no. 7, pp. 1051–1059, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. D. R. Gouldesbrough, J. E. Bell, and A. Gordon, “Use of immunohistochemical methods in the differential diagnosis between primary cerebellar haemangioblastoma and metastatic renal carcinoma,” Journal of Clinical Pathology, vol. 41, no. 8, pp. 861–865, 1988. View at Google Scholar · View at Scopus
  50. S. Roy, A. Chu, J. Q. Trojanowski, and P. J. Zhang, “D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas,” Acta Neuropathologica, vol. 109, no. 5, pp. 497–502, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. S.-M. Jung and T.-T. Kuo, “Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma,” Modern Pathology, vol. 18, no. 6, pp. 788–794, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. M. F. Acikalin, U. Oner, N. Tel, O. Paşaoǧlu, and F. Altinel, “Supratentorial hemangioblastoma: a case report and review of the literature,” Archives of Pathology & Laboratory Medicine, vol. 127, no. 9, pp. e382–e384, 2003. View at Google Scholar · View at Scopus
  53. R. R. Sharma, I. P. Cast, and C. O'Brien, “Supratentorial haemangioblastoma not associated with Von Hippel Lindau complex or polycythaemia: case report and literature review,” British Journal of Neurosurgery, vol. 9, no. 1, pp. 81–84, 1995. View at Google Scholar · View at Scopus
  54. H. Takei, M. B. Bhattacharjee, A. Rivera, Y. Dancer, and S. Z. Powell, “New immunohistochemical markers in the evaluation of central nervous system tumors: a review of 7 selected adult and pediatric brain tumors,” Archives of Pathology and Laboratory Medicine, vol. 131, no. 2, pp. 234–241, 2007. View at Google Scholar · View at Scopus
  55. A. Oviedo, D. Pang, J. Zovickian, and M. Smith, “Clear cell meningioma: case report and review of the literature,” Pediatric and Developmental Pathology, vol. 8, no. 3, pp. 386–390, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. D. Nonaka, J. Rodriguez, and J. Rosai, “Extraneural hemangioblastoma: a report of 5 cases,” American Journal of Surgical Pathology, vol. 31, no. 10, pp. 1545–1551, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. N. Gökden, O. Nappi, P. E. Swanson et al., “Renal cell carcinoma with rhabdoid features,” American Journal of Surgical Pathology, vol. 24, no. 10, pp. 1329–1338, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. D. C. Chhieng and G. P. Siegal, “Wandering chordoma—a mid-line crisis?” Skeletal Radiology, vol. 36, no. 1, pp. 1–3, 2007. View at Publisher · View at Google Scholar · View at Scopus